Index Copernicus Value: 60.8
Enliven: Gynecology and Obstetrics is an Open access, peer reviewed international journal and it aims to publish different types of articles on emerging developments and supports current and upcoming research in the field of gynecology. This journal also allows articles on obstetrics.
This journal will support the budding scientists, scholars, academicians, researchers, and students by providing Open access platform for publishing their work.
This journal will follow the peer review policies and will bode Open access in having quality research output.
This journal combines the innovative scientific ideas and ways in gynecology, obstetrics and all other related disciplines to have an innovative output.
Enliven: Gynecology and Obstetrics invites articles from authors and we assure authors that articles received will be processed with the best policies and will disseminate the articles to the right field.
Enliven: Gynecology and Obstetrics aims to publish recent studies, original research, innovations, discoveries and developments in obstetrics, prenatal diagnosis, materno-fetal medicine, perinatology, general gynecology, gynecologic oncology, uro-gynecology, infectious diseases, and all other related areas.
Official Media Partners:
The STD 2019 conference will relay the latest technologies and innovations relevant to sexually transmitted diseases and related fields. The two days meeting is going to be an event to look forward to for its enlightening symposiums & workshops from established experts of the field, exceptional keynote sessions directed by the best in the business. It will also prove to be a brilliant open door for the representatives from Universities, Institutes and Societies to cooperate with the world class researchers and an outstanding opportunity for businesses keen at expanding their global market reach.
iWomen Health 2019 includes nearly every permutation of knowledge, innovation, technology and networking. We have an objective of creating an international forum for academicians, practitioners, health and business professionals who work across the broad field of women's health to share latest advancement and research that will enable the best outcomes for women patients.
iWomen Health's focus includes the dissemination of translational research and evidence-based practices for disease prevention, diagnosis, and treatment for women across the lifespan. This program provides three days of robust discussions in the field of breast cancer, menopause, prenatal and neonatal care, reproduction, infertility, hormonal replacement therapy and more.
PCOS Congress 2018 presenting world class platform to explore innovative techniques to avoid infertility and to take pride of inviting all the participants, researchers, Gynaecologists, Obstetricians, Fertility specialists, students of medical universities, upcoming researchers, PCOS 2018 providing a global framework to evade Polycystic Ovarian Syndrome and to make a healthy world.
- Abstract View Pdf Full Text
Eventual capability of fetomaternal hemorrhage with expansion and evacuation agenda.
- If treatment concern are too great with ongoing guidelines, under doses will decision in capability and amount hoard.
Entombconsignment layoff and diabetes mellitus in a after gestation.
- A extended IDI is an autonomous exposure aspect for the advancement of diabetes at the period of a subsequent delivery.
Effect of Gestational load benefit on exploratory of employment subsequently cesarean achievement.
- The constitutional conclusion was fortunate vaginal delivery after cesarean secondary conclusion included different perinatal morbidity markers.
Impact of way of life advise on well being complementary character of life in mother at huge liability for pregnancy diabetes.
- A huge prevalence of GDM in two gether study groups may have confounded the impact of the intervention.
Sheath Accreta is a rainbow of certain exposure,analysis and catatonia.
- The capability for unexpectedly morbidity underline the requirement for revised diagnostic apparatus for placenta accreta spectrum.